To transform the global insulin market by offering sustainable and economical solutions for diabetes care, enhancing millions of lives.
To lead in developing and commercializing plant-based pharmaceuticals, starting with our innovative insulin product, Plansulin.
With the insulin market projected to grow significantly, Plansulin targets capturing a substantial market share by addressing cost and sustainability barriers. Our strategy includes forming alliances with healthcare sectors to ensure rapid adoption.
Our technology facilitates the launch of production facilities globally, reducing costs and enhancing supply chain efficiencies—a localized strategy that accelerates market penetration and compliance with regional regulations.